B. Riley Asset Management, LLC Harvard Bioscience Inc Transaction History

B. Riley Asset Management, LLC

  • $88.2 Million
  • Q4 2024

A detailed history of B. Riley Asset Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, B. Riley Asset Management, LLC holds 1,351,397 shares of HBIO stock, worth $1.59 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares
1,351,397
Previous 1,535,820 12.01%
Holding current value
$1.59 Million
Previous $4.13 Million 30.99%
% of portfolio
3.23%
Previous 2.43%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$2.02 - $2.82 $372,534 - $520,072
-184,423 Reduced 12.01%
1,351,397 $2.85 Million
Q3 2024

Dec 04, 2024
BUY
$2.64 - $3.54 $2.49 Million - $3.34 Million
943,108 Added 159.12%
1,535,820 $4.13 Million
Q3 2024

Nov 14, 2024
SELL
$2.64 - $3.54 $2.49 Million - $3.34 Million
-943,108 Reduced 61.41%
592,712 $1.59 Million
Q2 2024

Aug 14, 2024
SELL
$2.77 - $4.63 $3.6 Million - $6.01 Million
-1,299,121 Reduced 45.83%
1,535,820 $4.38 Million
Q1 2024

May 15, 2024
SELL
$4.02 - $5.39 $419,434 - $562,376
-104,337 Reduced 3.55%
2,834,941 $12 Million
Q4 2023

Feb 14, 2024
SELL
$4.0 - $5.49 $1.29 Million - $1.78 Million
-323,717 Reduced 9.92%
2,939,278 $15.7 Million
Q3 2023

Nov 14, 2023
BUY
$4.0 - $5.82 $800,128 - $1.16 Million
200,032 Added 6.53%
3,262,995 $14 Million
Q2 2023

Aug 14, 2023
SELL
$4.19 - $6.16 $1.45 Million - $2.13 Million
-345,833 Reduced 10.15%
3,062,963 $16.8 Million
Q1 2023

May 15, 2023
BUY
$2.45 - $4.22 $542,675 - $934,730
221,500 Added 6.95%
3,408,796 $14.3 Million
Q4 2022

Feb 14, 2023
BUY
$2.12 - $2.86 $3.12 Million - $4.21 Million
1,472,061 Added 85.82%
3,187,296 $8.83 Million
Q3 2022

Nov 14, 2022
BUY
$2.33 - $3.92 $397,470 - $668,704
170,588 Added 11.04%
1,715,235 $4.39 Million
Q2 2022

Aug 16, 2022
BUY
$3.28 - $6.42 $2.12 Million - $4.15 Million
646,211 Added 71.93%
1,544,647 $5.56 Million
Q1 2022

May 16, 2022
BUY
$5.16 - $7.14 $1.51 Million - $2.09 Million
292,042 Added 48.16%
898,436 $5.58 Million
Q4 2021

Feb 10, 2022
SELL
$6.37 - $8.18 $476,361 - $611,716
-74,782 Reduced 10.98%
606,394 $4.28 Million
Q4 2021

Feb 09, 2022
BUY
$6.37 - $8.18 $4.34 Million - $5.57 Million
681,176 New
681,176 $4.18 Million

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
31.3M
Call Options Held
0
Put Options Held
15K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $49.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track B. Riley Asset Management, LLC Portfolio

Follow B. Riley Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Riley Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on B. Riley Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email